Zions Bancorporation N.A. Has $215,000 Stake in MetLife, Inc. (NYSE:MET)

Zions Bancorporation N.A. grew its holdings in MetLife, Inc. (NYSE:MET) by 11.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,610 shares of the financial services provider’s stock after purchasing an additional 260 shares during the period. Zions Bancorporation N.A.’s holdings in MetLife were worth $215,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Plato Investment Management Ltd lifted its stake in MetLife by 31.5% in the 3rd quarter. Plato Investment Management Ltd now owns 24,683 shares of the financial services provider’s stock worth $2,034,000 after acquiring an additional 5,916 shares in the last quarter. Main Street Financial Solutions LLC purchased a new stake in shares of MetLife in the third quarter worth approximately $234,000. Kovack Advisors Inc. boosted its holdings in shares of MetLife by 317.1% during the third quarter. Kovack Advisors Inc. now owns 17,529 shares of the financial services provider’s stock worth $1,446,000 after purchasing an additional 13,326 shares during the period. Carlton Hofferkamp & Jenks Wealth Management LLC acquired a new position in MetLife in the 3rd quarter valued at approximately $352,000. Finally, Aptus Capital Advisors LLC boosted its stake in shares of MetLife by 4.8% during the 3rd quarter. Aptus Capital Advisors LLC now owns 10,885 shares of the financial services provider’s stock valued at $898,000 after buying an additional 498 shares during the period. Institutional investors and hedge funds own 89.81% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on MET shares. TD Cowen started coverage on MetLife in a report on Wednesday, October 9th. They set a “buy” rating and a $97.00 price objective for the company. Jefferies Financial Group raised their price target on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, September 27th. Barclays lowered their price target on MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a research note on Thursday, October 31st. Morgan Stanley reduced their target price on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a research note on Monday, August 19th. Finally, StockNews.com upgraded shares of MetLife from a “hold” rating to a “buy” rating in a report on Tuesday. Fourteen investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $88.46.

MetLife Stock Up 0.9 %

Shares of MET stock opened at $83.33 on Friday. MetLife, Inc. has a 12 month low of $61.61 and a 12 month high of $86.94. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The firm has a market cap of $57.70 billion, a PE ratio of 16.80, a price-to-earnings-growth ratio of 0.74 and a beta of 1.05. The stock has a 50 day moving average of $81.42 and a 200-day moving average of $75.48.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be given a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 annualized dividend and a yield of 2.62%. MetLife’s dividend payout ratio is 43.95%.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.